Where Is the Portacaval Lymph Node Located?

The portacaval lymph node sits in a narrow gap between two of the abdomen’s largest blood vessels: the portal vein in front and the inferior vena cava behind. This sliver of tissue, called the portacaval space, lies deep in the upper abdomen just behind the liver, and it is a spot that radiologists, surgeons, and oncologists pay close attention to because enlarged nodes here can signal anything from harmless reactive changes to advanced cancer.

The Portacaval Space and What Lives Inside It

To picture where the portacaval lymph node actually is, you need to understand the small anatomical corridor it calls home. The portal vein carries nutrient-rich blood from the intestines toward the liver. The inferior vena cava (IVC) is the body’s largest vein, running along the spine and returning blood to the heart. Between these two major vessels is a tight compartment, roughly at the level of the upper pancreas and the underside of the liver. That compartment is the portacaval space.

The portacaval space is not empty except for lymph nodes. It contains a surprisingly busy collection of structures for such a small area. The caudate lobe of the liver, including its papillary process, extends into this space. Part of the head of the pancreas may border it. Small blood vessels, including occasionally a replaced or accessory right hepatic artery, can run through it. The cystic duct passes nearby, and the opening to the lesser sac of the peritoneum, called the epiploic foramen, sits at the space’s edge. Fat and connective tissue fill the remaining gaps.¹ Lymph nodes within this space are considered normal residents, not abnormalities by themselves.²

The location is deep enough that you cannot feel portacaval lymph nodes on a physical exam the way you can feel swollen nodes in your neck or armpit. They are visible only on imaging, most commonly on CT scans or MRI of the abdomen. Their position wedged between two large vessels gives them a distinctive appearance on cross-sectional imaging, which helps radiologists identify them and distinguish them from other structures in the area.

What Portacaval Lymph Nodes Look Like on Imaging

On a CT scan, portacaval lymph nodes tend to appear rectangular or oval in shape when viewed in a standard axial (cross-sectional) slice. This sets them apart from nearby celiac lymph nodes, which tend to look rounder. A normal portacaval node can measure up to about 1.3 centimeters in the front-to-back dimension and still be considered within normal limits.¹ That is a somewhat generous upper limit compared to many other lymph node stations in the abdomen, where 1.0 centimeter is often used as the threshold for “enlarged.” The elongated shape of the portacaval space itself likely accounts for the slightly larger allowable size; the nodes stretch to fit the corridor they occupy.

Radiologists typically measure the short-axis diameter of a lymph node to decide whether it is abnormally large. When a portacaval node exceeds these normal limits, the radiology report will usually describe “portacaval lymphadenopathy,” which simply means the node is bigger than expected. The report may also note the node’s density, whether it enhances with contrast dye, and whether there are other enlarged nodes nearby. All of these details help narrow down the possible causes.

Why the Portacaval Space Drains What It Drains

Lymph nodes exist to filter lymphatic fluid from nearby organs and tissues. The portacaval lymph nodes receive drainage from the liver, parts of the biliary system, and portions of the pancreas and duodenum. This makes them a natural waystation for immune cells monitoring these organs. It also means that when disease affects the liver, bile ducts, gallbladder, or pancreatic head, the portacaval nodes are among the first to respond, whether by swelling in reaction to infection and inflammation or by harboring metastatic cancer cells that have spread from a nearby tumor.

Understanding which organs drain to this spot explains why doctors care so much about portacaval nodes in certain clinical scenarios. A swollen portacaval node in someone with liver cirrhosis tells a different story than a swollen portacaval node in someone with a known pancreatic mass. The same anatomical address carries very different clinical significance depending on the context.

Enlarged Portacaval Nodes in Liver Disease

The single most common reason for portacaval lymph nodes to enlarge is chronic liver disease, particularly cirrhosis and chronic viral hepatitis. A large study of over 500 patients with end-stage cirrhosis who underwent CT scanning found that when enlarged abdominal lymph nodes were present, the portacaval space and the porta hepatis (the entrance to the liver) were the most common locations.³ The nodes in that study ranged from about 1.1 centimeters to as large as 3.0 by 4.5 centimeters. When pathologists examined these nodes under the microscope, the overwhelming majority turned out to be benign reactive hyperplasia, meaning the immune tissue was simply enlarged from chronic stimulation. Only two of 253 patients with histologically examined nodes had malignant disease in those nodes.³

This finding is important because it means an enlarged portacaval node in a patient already known to have cirrhosis is far more likely to be harmless than dangerous. Chronic liver inflammation drives a constant low-grade immune response, and the nearby lymph nodes swell as a result. Radiologists who read many abdominal CTs come to expect portacaval lymphadenopathy in cirrhotic patients, though they still note it in reports in case the clinical picture changes over time.

A separate retrospective study looking at almost 500 patients with portacaval lymphadenopathy found on CT confirmed a similar pattern. Roughly 60 percent of cases were explained by a known local condition or systemic lymphadenopathy, and about 10 percent were attributable to cirrhosis or chronic viral hepatitis specifically. Around 30 percent were considered incidental findings with no immediately obvious explanation.⁴ That last group, the incidental discoveries, often causes the most anxiety for patients and their doctors, because a swollen lymph node without an obvious cause raises the question of whether cancer is hiding somewhere.

Incidental Portacaval Lymphadenopathy

Abdominal CT scans are ordered for all sorts of reasons: kidney stones, abdominal pain, post-surgical follow-up, trauma evaluation. When the radiologist notices a plump portacaval lymph node in a patient who was scanned for something unrelated, the finding lands in the report as an incidental observation. The patient and referring doctor are left wondering what, if anything, to do about it.

The evidence suggests that in many of these cases, the finding is benign. Portacaval lymphadenopathy explained by incidental causes in about a third of patients in one cohort required no specific treatment or urgent workup.⁴ However, the clinical approach usually depends on the patient’s overall risk profile. If there is no history of liver disease, no known cancer, and the node is only mildly enlarged, monitoring with a follow-up scan in a few months is a reasonable approach. If the node is large, growing, or the patient has risk factors for hepatobiliary or pancreatic cancer, the threshold for biopsy or further imaging drops considerably.

One practical consideration: because the portacaval space sits deep in the abdomen surrounded by major blood vessels, biopsying a node in this location is technically more challenging than biopsying, say, an inguinal node in the groin. Interventional radiologists can access it using CT-guided needle biopsy, and endoscopic ultrasound-guided biopsy is another route, but neither is trivial. Clinicians weigh the procedural risk against the likelihood that the node is actually harboring something concerning.

When Portacaval Nodes Signal Cancer

For several cancers of the upper abdomen, the portacaval lymph node station is a recognized site of lymphatic spread. Hepatocellular carcinoma (liver cancer) is one of the best-studied examples. In a study examining FDG PET-CT scans in patients with hepatocellular carcinoma, regional lymph node metastases were the second most common extrahepatic finding, and portocaval nodes were involved in roughly a fifth of those patients who had regional nodal spread.⁵ The aortocaval and paraaortic stations were slightly more common sites of nodal spread, but portocaval nodes were clearly part of the pattern.

Gallbladder cancer is another malignancy where portacaval nodes matter. Because the gallbladder’s lymphatic drainage flows through the hepatoduodenal ligament and into the portacaval area, cancers arising in the gallbladder can seed these nodes relatively early. In surgical treatment of gallbladder cancer, clearing the portacaval and aortocaval lymph nodes is often part of the operation.⁶ Pancreatic head tumors and bile duct cancers also drain to this region, making portacaval node status relevant in staging and surgical planning for a range of upper-abdominal malignancies.

The key clinical implication is that a portacaval node that is new, enlarging, or disproportionately large relative to what the patient’s underlying condition would explain warrants concern for malignancy, especially in patients with known or suspected hepatobiliary or pancreatic tumors. In cancer staging, whether the portacaval nodes are positive or negative can influence whether a tumor is considered resectable and can change the entire treatment plan.

Surgical Access to the Portacaval Space

Getting to the portacaval space during surgery is not straightforward. The area is hemmed in by the portal vein, the IVC, the liver, and the head of the pancreas. Surgeons access it by performing a Kocher maneuver, which involves mobilizing the duodenum and the head of the pancreas to expose the IVC and the space behind it. Once the IVC is visible, the lymph nodes and connective tissue sitting between it and the portal vein can be dissected away.⁶

This dissection requires careful technique because of the major vessels on either side. Injury to the portal vein or IVC during lymph node removal can cause serious bleeding. The potential presence of a replaced or accessory right hepatic artery running through the portacaval space adds another layer of risk: if such a variant artery is present and is accidentally damaged, the blood supply to part of the liver can be compromised.¹ Surgeons review preoperative imaging carefully to identify any aberrant vessels before starting the dissection.

In recent years, laparoscopic and robotic approaches have been used for portacaval lymphadenectomy, particularly during radical cholecystectomy for gallbladder cancer. These minimally invasive techniques offer smaller incisions and potentially faster recovery, but they demand significant surgical expertise given the confined anatomy and proximity to major blood vessels. The feasibility of laparoscopic portacaval dissection has been demonstrated, but it remains a procedure that is limited to experienced hepatobiliary surgeons at specialized centers.

Vascular Variants That Complicate the Picture

One of the reasons the portacaval space gets extra attention in preoperative planning is that arterial anatomy in this region is notoriously variable. In a significant fraction of people, the right hepatic artery does not take its expected path from the common hepatic artery but instead arises from the superior mesenteric artery and courses through or near the portacaval space. This is called a replaced right hepatic artery, and it occurs in roughly one in five people, though exact estimates vary by study.

When this variant is present, the artery runs right through the zone where portacaval lymph nodes live. For a radiologist interpreting a CT scan, the artery can occasionally be confused with a lymph node if the scan is not contrast-enhanced or if the timing of contrast injection is not ideal. For a surgeon performing a lymphadenectomy, the variant artery is a structure that absolutely must be identified and preserved. Failure to recognize it preoperatively has historically led to inadvertent arterial injury during bile duct, pancreas, and liver surgeries.

Modern CT angiography has made it much easier to map out these variants before an operation. Surgeons now routinely review three-dimensional reconstructions of the arterial anatomy to check whether a replaced or accessory hepatic artery is present and, if so, exactly where it runs relative to the portacaval lymph nodes. This advance has made portacaval lymphadenectomy safer, though vigilance during the actual dissection remains essential.

How Portacaval Nodes Differ from Nearby Stations

The upper abdomen contains several lymph node groups that sit relatively close together but have different clinical associations. The celiac nodes cluster around the celiac trunk, the major artery that supplies the stomach, liver, and spleen. Paraaortic nodes line the sides of the aorta lower in the abdomen. Periportal nodes sit at the hilum of the liver, in and around the hepatoduodenal ligament. The portacaval nodes, as described, occupy the gap between the portal vein and IVC.

Each of these stations drains slightly different territory. Celiac nodes are often involved in gastric and esophageal cancers. Paraaortic nodes are more commonly affected by testicular, ovarian, and colorectal cancers. Portacaval and periportal nodes share overlapping drainage from the liver and biliary system, so they are sometimes enlarged together in the same patient. On imaging, the shape difference between portacaval nodes (elongated and rectangular on axial slices) and celiac nodes (rounder) helps radiologists tell them apart.¹

In practice, when a radiology report mentions portacaval lymphadenopathy, it is pointing to a specific location with a specific set of implications. If the same report also mentions celiac or paraaortic lymphadenopathy, the clinical picture shifts toward a more widespread process. The spatial pattern of which nodal stations are affected helps oncologists and surgeons reconstruct the likely path of lymphatic spread and decide how aggressively to treat.

What Patients Should Know About Portacaval Node Findings

If you have had an abdominal CT and the report mentions a portacaval lymph node, the first thing to keep in mind is that having a visible lymph node in this space is normal. Lymph nodes are supposed to be there. The question is whether the node is enlarged, and if so, whether the enlargement is explained by something already known about your health.

For people with chronic liver disease, especially cirrhosis or chronic hepatitis B or C, a mildly enlarged portacaval node is an expected finding and rarely a cause for alarm on its own. Your doctor may note it for tracking purposes but is unlikely to recommend invasive follow-up unless the node is very large or changing rapidly.

For people without liver disease, an incidentally discovered portacaval node that is borderline in size often prompts a recommendation for a follow-up scan in three to six months to see if it changes. If the node stays stable or shrinks, the concern drops. If it grows, further workup may be warranted. For people with a known or suspected cancer in the liver, bile ducts, gallbladder, or pancreas, portacaval node involvement can be a significant staging finding, and your oncologist or surgeon will factor it into treatment decisions.

The location is deep and inaccessible enough that there is nothing you can do to “feel” for a portacaval node the way you might check for swollen glands in your neck. These nodes are discovered and monitored entirely through imaging. If your radiology report includes this term and your doctor has not mentioned it, it is worth asking about on your next visit, even if the answer turns out to be reassuring.